McKesson Co. (MCK) Holdings Raised by Mainstay Capital Management LLC ADV

Mainstay Capital Management LLC ADV boosted its holdings in shares of McKesson Co. (NYSE:MCK) by 31.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,421 shares of the company’s stock after acquiring an additional 1,755 shares during the quarter. Mainstay Capital Management LLC ADV’s holdings in McKesson were worth $985,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Fort L.P. acquired a new stake in McKesson during the second quarter worth $110,000. Flagship Harbor Advisors LLC acquired a new stake in shares of McKesson in the second quarter valued at $118,000. Reilly Financial Advisors LLC grew its stake in shares of McKesson by 506.8% in the third quarter. Reilly Financial Advisors LLC now owns 898 shares of the company’s stock valued at $119,000 after buying an additional 750 shares in the last quarter. Bray Capital Advisors acquired a new stake in shares of McKesson in the third quarter valued at $123,000. Finally, FNY Investment Advisers LLC grew its stake in shares of McKesson by 88.6% in the third quarter. FNY Investment Advisers LLC now owns 1,120 shares of the company’s stock valued at $148,000 after buying an additional 526 shares in the last quarter. 85.46% of the stock is owned by institutional investors.

A number of equities research analysts have recently weighed in on the company. ValuEngine cut McKesson from a “sell” rating to a “strong sell” rating in a research note on Friday, November 16th. Mizuho reaffirmed a “hold” rating and issued a $133.00 price objective on shares of McKesson in a research note on Sunday, August 12th. Royal Bank of Canada set a $155.00 price objective on McKesson and gave the company a “hold” rating in a research note on Friday, October 26th. Finally, Barclays dropped their price objective on McKesson from $150.00 to $136.00 and set an “equal weight” rating for the company in a research note on Friday, October 26th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. McKesson has a consensus rating of “Hold” and an average target price of $150.26.

MCK opened at $124.50 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.56 and a current ratio of 0.99. McKesson Co. has a one year low of $117.19 and a one year high of $178.86. The stock has a market cap of $24.32 billion, a PE ratio of 9.87, a PEG ratio of 1.41 and a beta of 1.03.

McKesson (NYSE:MCK) last posted its earnings results on Thursday, October 25th. The company reported $3.60 EPS for the quarter, topping the Zacks’ consensus estimate of $3.28 by $0.32. McKesson had a return on equity of 26.55% and a net margin of 0.06%. The business had revenue of $53.08 billion for the quarter, compared to analysts’ expectations of $53.56 billion. As a group, equities research analysts anticipate that McKesson Co. will post 13.41 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 2nd. Stockholders of record on Monday, December 3rd will be given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date of this dividend is Friday, November 30th. McKesson’s dividend payout ratio (DPR) is currently 12.36%.

TRADEMARK VIOLATION WARNING: “McKesson Co. (MCK) Holdings Raised by Mainstay Capital Management LLC ADV” was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Read More: What is the LIBOR?

Want to see what other hedge funds are holding MCK? Visit to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit